305 related articles for article (PubMed ID: 7430640)
1. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.
Raso V; Griffin T
J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
3. [Selective cytotoxicity of an antibody-ricin A chain conjugate for human tumor cells].
Tonevitskiĭ AG
Mol Biol (Mosk); 1985; 19(4):1034-41. PubMed ID: 4047033
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P
Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
Liu XY; Zhen YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.
Colombatti M; Johnson VG; Skopicki HA; Fendley B; Lewis MS; Youle RJ
J Immunol; 1987 May; 138(10):3339-44. PubMed ID: 2437188
[TBL] [Abstract][Full Text] [Related]
8. The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.
Fulton RJ; Uhr JW; Vitetta ES
J Immunol; 1986 Apr; 136(8):3103-9. PubMed ID: 3958490
[TBL] [Abstract][Full Text] [Related]
9. Selective cytotoxicity of a ricin A-chain-anti-carcinoembryonic antigen antibody conjugate for a human colon adenocarcinoma cell line.
Griffin TW; Haynes LR; DeMartino JA
J Natl Cancer Inst; 1982 Oct; 69(4):799-805. PubMed ID: 6956757
[TBL] [Abstract][Full Text] [Related]
10. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T
J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795
[TBL] [Abstract][Full Text] [Related]
11. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
12. Hybrid antibodies with dual specificity for the delivery of ricin to immunoglobulin-bearing target cells.
Raso V; Griffin T
Cancer Res; 1981 Jun; 41(6):2073-8. PubMed ID: 7237414
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the helper function of murine T cells with Fab'-anti-L3T4 ricin A chain immunotoxin.
Street NE; Fulton RJ; Sanders VM; Vitetta ES
J Immunol; 1987 Sep; 139(5):1734-8. PubMed ID: 2957434
[TBL] [Abstract][Full Text] [Related]
14. In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain.
Fulton RJ; Uhr JW; Vitetta ES
Cancer Res; 1988 May; 48(9):2626-31. PubMed ID: 3258547
[TBL] [Abstract][Full Text] [Related]
15. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
Pietersz GA; Kanellos J; McKenzie IF
Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
[TBL] [Abstract][Full Text] [Related]
16. Target-cell cytotoxicity of a hybrid of Fab' on immunoglobulin and A-chain of ricin.
Masuho Y; Hara T
Gan; 1980 Dec; 71(6):759-65. PubMed ID: 7274624
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
Weil-Hillman G; Runge W; Jansen FK; Vallera DA
Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
[TBL] [Abstract][Full Text] [Related]
18. Studies on the contribution of putative anti-carbohydrate antibodies to the specificity of immunofluorescence staining of murine T cells with chicken anti-mouse (Fab')2 reagents.
Deluca D; Warr GW; Marchalonis JJ
J Immunol; 1982 Nov; 129(5):2025-32. PubMed ID: 6181155
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of tumor-reactive immunotoxins in tumor-bearing mice: effect of antibody valency and deglycosylation of the ricin A chain on clearance and tumor localization.
Fulton RJ; Tucker TF; Vitetta ES; Uhr JW
Cancer Res; 1988 May; 48(9):2618-25. PubMed ID: 3258546
[TBL] [Abstract][Full Text] [Related]
20. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
